• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索肿瘤坏死因子受体1:从发现到靶向治疗的发展

Exploring TNFR1: from discovery to targeted therapy development.

作者信息

Li Yingying, Ye Ruiwei, Dai Haorui, Lin Jiayi, Cheng Yue, Zhou Yonghong, Lu Yiming

机构信息

School of Medicine, Shanghai Baoshan Luodian Hospital, Shanghai University, Shanghai, 201908, China.

Department of Pharmacy, School of Medicine, Shanghai University, Shanghai, 200444, China.

出版信息

J Transl Med. 2025 Jan 15;23(1):71. doi: 10.1186/s12967-025-06122-0.

DOI:10.1186/s12967-025-06122-0
PMID:39815286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11734553/
Abstract

This review seeks to elucidate the therapeutic potential of tumor necrosis factor receptor 1 (TNFR1) and enhance our comprehension of its role in disease mechanisms. As a critical cell-surface receptor, TNFR1 regulates key signaling pathways, such as nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK), which are associated with pro-inflammatory responses and cell death. The intricate regulatory mechanisms of TNFR1 signaling and its involvement in various diseases, including inflammatory disorders, infectious diseases, cancer, and metabolic syndromes, have attracted increasing scholarly attention. Given the potential risks associated with targeting tumor necrosis factor-alpha (TNF-α), selective inhibition of the TNFR1 signaling pathway has been proposed as a promising strategy to reduce side effects and enhance therapeutic efficacy. This review emphasizes the emerging field of targeted therapies aimed at selectively modulating TNFR1 activity, identifying promising therapeutic strategies that exploit TNFR1 as a drug target through an evaluation of current clinical trials and preclinical studies. In conclusion, this study contributes novel insights into the biological functions of TNFR1 and presents potential therapeutic strategies for clinical application, thereby having substantial scientific and clinical significance.

摘要

本综述旨在阐明肿瘤坏死因子受体1(TNFR1)的治疗潜力,并增进我们对其在疾病机制中作用的理解。作为一种关键的细胞表面受体,TNFR1调节关键的信号通路,如与促炎反应和细胞死亡相关的核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)。TNFR1信号传导的复杂调节机制及其在各种疾病中的参与,包括炎症性疾病、传染病、癌症和代谢综合征,已引起越来越多的学术关注。鉴于靶向肿瘤坏死因子-α(TNF-α)存在潜在风险,选择性抑制TNFR1信号通路已被提议作为一种有前景的策略,以减少副作用并提高治疗效果。本综述强调了旨在选择性调节TNFR1活性的靶向治疗新兴领域,通过评估当前的临床试验和临床前研究,确定将TNFR1作为药物靶点的有前景的治疗策略。总之,本研究为TNFR1的生物学功能提供了新的见解,并提出了潜在的临床应用治疗策略,具有重要的科学和临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/c67e3988af62/12967_2025_6122_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/8e6172c53138/12967_2025_6122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/208651b0dc10/12967_2025_6122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/8900ba98215e/12967_2025_6122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/300ec8b1646d/12967_2025_6122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/c67e3988af62/12967_2025_6122_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/8e6172c53138/12967_2025_6122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/208651b0dc10/12967_2025_6122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/8900ba98215e/12967_2025_6122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/300ec8b1646d/12967_2025_6122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/11734553/c67e3988af62/12967_2025_6122_Fig5_HTML.jpg

相似文献

1
Exploring TNFR1: from discovery to targeted therapy development.探索肿瘤坏死因子受体1:从发现到靶向治疗的发展
J Transl Med. 2025 Jan 15;23(1):71. doi: 10.1186/s12967-025-06122-0.
2
Protein Kinase-Mediated Decision Between the Life and Death.蛋白激酶介导的生死抉择。
Adv Exp Med Biol. 2021;1275:1-33. doi: 10.1007/978-3-030-49844-3_1.
3
Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases.肿瘤坏死因子受体-1(TNFR1)选择性抑制治疗自身免疫性疾病。
Cytokine Growth Factor Rev. 2020 Oct;55:80-85. doi: 10.1016/j.cytogfr.2020.03.002. Epub 2020 Apr 12.
4
Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.心力衰竭中不同的肿瘤坏死因子受体相关重塑反应:核因子-κB和炎症激活的作用
Circulation. 2009 Mar 17;119(10):1386-97. doi: 10.1161/CIRCULATIONAHA.108.802918. Epub 2009 Mar 2.
5
TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.TRAF2在肿瘤坏死因子受体诱导的向核因子κB、丝裂原活化蛋白激酶的信号传导及细胞死亡过程中的多重任务作用
Biochem Pharmacol. 2016 Sep 15;116:1-10. doi: 10.1016/j.bcp.2016.03.009. Epub 2016 Mar 16.
6
ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.ST6Gal-I 唾液酸转移酶通过 TNF 受体 1(TNFR1)死亡受体的唾液酸化促进肿瘤坏死因子(TNF)介导的癌细胞存活。
J Biol Chem. 2018 Feb 2;293(5):1610-1622. doi: 10.1074/jbc.M117.801480. Epub 2017 Dec 12.
7
TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury.缺血性急性肾损伤时 TNFR1 依赖性的肺部细胞凋亡。
Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L449-59. doi: 10.1152/ajplung.00301.2011. Epub 2012 Jun 22.
8
Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.布雷菲德菌素A抑制的鸟嘌呤核苷酸交换因子1(BIG1)调控肿瘤坏死因子受体相关因子2(TRAF2)募集至肿瘤坏死因子受体1(TNFR1)信号复合物。
Int J Mol Sci. 2016 Nov 9;17(11):1869. doi: 10.3390/ijms17111869.
9
TNFR1/p38αMAPK signaling in Nex + supraspinal neurons regulates estrogen-dependent chronic neuropathic pain.Nex⁺ 上脊髓神经元中的 TNFR1/p38αMAPK 信号转导调节雌激素依赖性慢性神经病理性疼痛。
Brain Behav Immun. 2024 Jul;119:261-271. doi: 10.1016/j.bbi.2024.03.050. Epub 2024 Apr 1.
10
A Network Pharmacology-Based Analysis of the Protective Mechanism of Miao Medicine Xuemaitong Capsule Against Secondary Brain Damage in the Ischemic Area Surrounding Intracerebral Hemorrhage.基于网络药理学的苗药血脉通胶囊对脑出血周围缺血区继发性脑损伤保护机制的分析
J Pharmacol Exp Ther. 2021 Apr;377(1):86-99. doi: 10.1124/jpet.120.000083. Epub 2020 Dec 11.

引用本文的文献

1
Macrophages in rosacea: pathogenesis and therapeutic potential.酒渣鼻中的巨噬细胞:发病机制与治疗潜力
Front Immunol. 2025 Jul 31;16:1595493. doi: 10.3389/fimmu.2025.1595493. eCollection 2025.
2
The role of tumor necrosis factor receptor superfamily in cancer: insights into oncogenesis, progression, and therapeutic strategies.肿瘤坏死因子受体超家族在癌症中的作用:对肿瘤发生、进展及治疗策略的见解
NPJ Precis Oncol. 2025 Aug 6;9(1):275. doi: 10.1038/s41698-025-00990-x.
3
Identification of palmitoylated biomarkers in non-alcoholic fatty liver disease via integrated bioinformatics analysis and machine learning.

本文引用的文献

1
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancer.PARP 抑制剂通过 TNF-caspase8-GSDMD/E 轴触发细胞焦亡增强卵巢癌细胞的抗肿瘤免疫反应。
J Immunother Cancer. 2024 Oct 4;12(10):e009032. doi: 10.1136/jitc-2024-009032.
2
TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function.TNFR1 信号通路通过限制树突状细胞数量和功能促进胰腺肿瘤生长。
Cell Rep Med. 2024 Sep 17;5(9):101696. doi: 10.1016/j.xcrm.2024.101696. Epub 2024 Aug 22.
3
Derivation of novel metabolic pathway score identifies alanine metabolism as a targetable influencer of TNF-alpha signaling.
通过综合生物信息学分析和机器学习鉴定非酒精性脂肪性肝病中的棕榈酰化生物标志物
Sci Rep. 2025 Aug 1;15(1):28177. doi: 10.1038/s41598-025-13477-3.
4
VPS37A Activates the Autophagy-Lysosomal Pathway for TNFR1 Degradation and Induces NF-B-Regulated Cell Death under Metabolic Stress in Colorectal Cancer.VPS37A激活自噬-溶酶体途径以降解TNFR1,并在结直肠癌的代谢应激下诱导NF-κB调节的细胞死亡。
Oncol Res. 2025 Jul 18;33(8):2085-2105. doi: 10.32604/or.2025.065739. eCollection 2025.
5
Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders.神经炎症:神经系统疾病中的机制、双重作用及治疗策略
Curr Issues Mol Biol. 2025 Jun 4;47(6):417. doi: 10.3390/cimb47060417.
6
N-acetylcysteine reduces the hepatic complications of social isolation stress through modulation of interleukin 1 and 6 gene expression and liver enzymes in mice.N-乙酰半胱氨酸通过调节小鼠白细胞介素1和6的基因表达及肝酶,减轻社会隔离应激引起的肝脏并发症。
Sci Rep. 2025 Jul 2;15(1):23166. doi: 10.1038/s41598-025-01557-3.
7
The Dual Role of TRADD in Liver Disease: From Cell Death Regulation to Inflammatory Microenvironment Remodeling.TRADD在肝脏疾病中的双重作用:从细胞死亡调控到炎症微环境重塑
Int J Mol Sci. 2025 Jun 19;26(12):5860. doi: 10.3390/ijms26125860.
8
Exploration of Cytokines That Impact the Therapeutic Efficacy of Mesenchymal Stem Cells in Alzheimer's Disease.影响间充质干细胞在阿尔茨海默病中治疗效果的细胞因子探索
Bioengineering (Basel). 2025 Jun 12;12(6):646. doi: 10.3390/bioengineering12060646.
9
Advances in pharmacological research on myocardial remodeling agents: A decade in review.心肌重塑药物的药理学研究进展:十年回顾
Medicine (Baltimore). 2025 Jun 6;104(23):e42757. doi: 10.1097/MD.0000000000042757.
10
TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection.Toll样受体2(TLR2)或Toll样受体4(TLR4)刺激可诱导巨噬细胞中跨膜肿瘤坏死因子(TNF)驱动的启动,从而改善对随后金黄色葡萄球菌感染的清除。
J Innate Immun. 2025;17(1):302-319. doi: 10.1159/000546011. Epub 2025 May 28.
新型代谢途径评分的推导确定丙氨酸代谢是TNF-α信号传导的一个可靶向影响因素。
Heliyon. 2024 Jun 22;10(13):e33502. doi: 10.1016/j.heliyon.2024.e33502. eCollection 2024 Jul 15.
4
Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex.基于肽的变构抑制剂靶向 TNFR1 构象活性区域并使受体配体信号复合物失活。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2308132121. doi: 10.1073/pnas.2308132121. Epub 2024 Mar 29.
5
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity.用于肝癌成像和靶向治疗的缺氧激活的ADCC增强型人源化抗CD147抗体,具有更高的选择性。
MedComm (2020). 2024 Mar 11;5(3):e512. doi: 10.1002/mco2.512. eCollection 2024 Mar.
6
Cellular heterogeneity in TNF/TNFR1 signalling: live cell imaging of cell fate decisions in single cells.肿瘤坏死因子/肿瘤坏死因子受体1信号传导中的细胞异质性:单细胞中细胞命运决定的活细胞成像
Cell Death Dis. 2024 Mar 11;15(3):202. doi: 10.1038/s41419-024-06559-z.
7
The Role of TNF-α in Alzheimer's Disease: A Narrative Review.TNF-α 在阿尔茨海默病中的作用:叙述性综述。
Cells. 2023 Dec 26;13(1):54. doi: 10.3390/cells13010054.
8
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment.肿瘤微环境中通过 TNF 受体 1 和 TNF 受体 2 进行肿瘤坏死因子信号转导的分子机制。
Curr Opin Immunol. 2024 Feb;86:102409. doi: 10.1016/j.coi.2023.102409. Epub 2023 Dec 27.
9
Expression of TNFR1, VEGFA, CD147 and MCT1 as early biomarkers of diabetes complications and the impact of aging on this profile.TNFR1、VEGFA、CD147 和 MCT1 的表达作为糖尿病并发症的早期生物标志物,以及衰老对该特征的影响。
Sci Rep. 2023 Oct 20;13(1):17927. doi: 10.1038/s41598-023-41061-0.
10
TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis.与核因子κB激活相关的肿瘤坏死因子受体1和肿瘤坏死因子受体2驱动肺癌进展、细胞去分化和转移。
Cancers (Basel). 2023 Aug 28;15(17):4299. doi: 10.3390/cancers15174299.